Damora Therapeutics, Inc. (DMRA)
24.77
+0.02
(+0.08%)
USD |
NASDAQ |
Sep 16, 11:53
Damora Therapeutics 1 Year Total Returns (Daily) : 774.6% for Sept. 15, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 15, 2026 | 774.6% |
| September 14, 2026 | 889.2% |
| September 11, 2026 | 903.6% |
| September 10, 2026 | 800.7% |
| September 09, 2026 | 918.2% |
| September 08, 2026 | 844.0% |
| September 04, 2026 | 902.0% |
| September 03, 2026 | 842.8% |
| September 02, 2026 | 839.3% |
| September 01, 2026 | 784.9% |
| August 31, 2026 | 786.2% |
| August 28, 2026 | 800.6% |
| August 27, 2026 | 810.7% |
| August 26, 2026 | 805.2% |
| August 25, 2026 | 800.6% |
| August 24, 2026 | 807.5% |
| August 21, 2026 | 811.8% |
| August 20, 2026 | 796.8% |
| August 19, 2026 | 862.6% |
| August 18, 2026 | 843.6% |
| August 17, 2026 | 819.8% |
| August 14, 2026 | 804.1% |
| August 13, 2026 | 814.6% |
| August 12, 2026 | 844.6% |
| August 11, 2026 | 798.2% |
| Date | Value |
|---|---|
| August 10, 2026 | 774.0% |
| August 07, 2026 | 817.8% |
| August 06, 2026 | 778.8% |
| August 05, 2026 | 806.8% |
| August 04, 2026 | 786.9% |
| August 03, 2026 | 791.1% |
| July 31, 2026 | 781.2% |
| July 30, 2026 | 779.8% |
| July 29, 2026 | 689.1% |
| July 28, 2026 | 680.4% |
| July 27, 2026 | 685.1% |
| July 24, 2026 | 658.0% |
| July 23, 2026 | 668.6% |
| July 22, 2026 | 723.9% |
| July 21, 2026 | 817.7% |
| July 20, 2026 | 819.8% |
| July 17, 2026 | 762.5% |
| July 16, 2026 | 764.0% |
| July 15, 2026 | 771.0% |
| July 14, 2026 | 694.6% |
| July 13, 2026 | 692.1% |
| July 10, 2026 | 722.2% |
| July 09, 2026 | 805.3% |
| July 08, 2026 | 729.2% |
| July 07, 2026 | 823.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.47% |
| Alnylam Pharmaceuticals, Inc. | -48.33% |
| Anika Therapeutics, Inc. | 141.7% |
| Savara, Inc. | 45.71% |
| Vericel Corp. | 26.42% |